Beneficial effects of HDAC inhibitors such as Givinostat, were previously demonstrated in mdx mice and DMD patients to stimulate the expression of the activin binding protein follistatin, whose main activity is to block TGF-β signaling27,56,107. This evidence concerns the gene HDAC9 and Duchenne muscular dystrophy.